ResearcherGerman Cancer Research CenterNo recent work listed
Carmen Timke
Matched on ORCID iD 0000-0003-0256-6625; OpenAlex author ID A5078178595. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 12
2011: 1 paper · 2012: 2 papers
Papers 3
- Clinical phase I/II trial to investigate neoadjuvant intensity-modulated short term radiation therapy (5 × 5 Gy) and intraoperative radiation therapy (15 Gy) i… First author DOI 10.1186/1471-2407-12-112↗
- Aggressive local treatment containing intraoperative radiation therapy (IORT) for patients with isolated local recurrences of pancreatic cancer: a retrospectiv… First author DOI 10.1186/1471-2407-12-295↗
- Randomized controlled phase I/II study to investigate immune stimulatory effects by low dose radiotherapy in primarily operable pancreatic cancer. Co-author DOI 10.1186/1471-2407-11-134↗
Closest collaborators
The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Peter Ernst Huber · 3 shared papers, 2011–2012 · strength 0.08
- Paper Aggressive local treatment containing intraoperative radiation therapy (IORT) for patients with isolated local recurren… DOI 10.1186/1471-2407-12-295↗
- Paper Clinical phase I/II trial to investigate neoadjuvant intensity-modulated short term radiation therapy (5 × 5 Gy) and in… DOI 10.1186/1471-2407-12-112↗
- Paper Randomized controlled phase I/II study to investigate immune stimulatory effects by low dose radiotherapy in primarily … DOI 10.1186/1471-2407-11-134↗
- Jürgen Debus · 3 shared papers, 2011–2012 · strength 0.08
- Paper Aggressive local treatment containing intraoperative radiation therapy (IORT) for patients with isolated local recurren… DOI 10.1186/1471-2407-12-295↗
- Paper Clinical phase I/II trial to investigate neoadjuvant intensity-modulated short term radiation therapy (5 × 5 Gy) and in… DOI 10.1186/1471-2407-12-112↗
- Paper Randomized controlled phase I/II study to investigate immune stimulatory effects by low dose radiotherapy in primarily … DOI 10.1186/1471-2407-11-134↗
- Falk Roeder · 3 shared papers, 2011–2012 · strength 0.08
- Paper Aggressive local treatment containing intraoperative radiation therapy (IORT) for patients with isolated local recurren… DOI 10.1186/1471-2407-12-295↗
- Paper Clinical phase I/II trial to investigate neoadjuvant intensity-modulated short term radiation therapy (5 × 5 Gy) and in… DOI 10.1186/1471-2407-12-112↗
- Paper Randomized controlled phase I/II study to investigate immune stimulatory effects by low dose radiotherapy in primarily … DOI 10.1186/1471-2407-11-134↗
- Jens Werner · 3 shared papers, 2011–2012 · strength 0.08
- Paper Aggressive local treatment containing intraoperative radiation therapy (IORT) for patients with isolated local recurren… DOI 10.1186/1471-2407-12-295↗
- Paper Clinical phase I/II trial to investigate neoadjuvant intensity-modulated short term radiation therapy (5 × 5 Gy) and in… DOI 10.1186/1471-2407-12-112↗
- Paper Randomized controlled phase I/II study to investigate immune stimulatory effects by low dose radiotherapy in primarily … DOI 10.1186/1471-2407-11-134↗
- Frank W. Hensley · 2 shared papers, 2012 · strength 0.06
- Paper Aggressive local treatment containing intraoperative radiation therapy (IORT) for patients with isolated local recurren… DOI 10.1186/1471-2407-12-295↗
- Paper Clinical phase I/II trial to investigate neoadjuvant intensity-modulated short term radiation therapy (5 × 5 Gy) and in… DOI 10.1186/1471-2407-12-112↗
- Robert C Krempien · 1 shared paper, 2012 · strength 0.03
- Werner Hartwig · 1 shared paper, 2012 · strength 0.03
- Thilo Hackert · 1 shared paper, 2012 · strength 0.03
- Philipp Beckhove · 1 shared paper, 2011 · strength 0.02
- Moritz Koch · 1 shared paper, 2011 · strength 0.02
- Christoph Reißfelder · 1 shared paper, 2011 · strength 0.02
- Jürgen Weitz · 1 shared paper, 2011 · strength 0.02
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.